Clinical trials
Phase 2 Diabetic Retinopathy trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2008 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2015 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Terminated | 3 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Oxurion | 2 |
| Quark Pharmaceuticals | 2 |
| ThromboGenics | 2 |
| Bayer | 1 |
| Boehringer Ingelheim | 1 |
| GlaxoSmithKline | 1 |
| Novartis Pharmaceuticals | 1 |
| Pfizer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetic Retinopathy | 11 |
| Diabetes Mellitus | 3 |
| Macular Edema | 3 |
| Choroidal Neovascularization | 1 |
| Diabetes Complications | 1 |
| Disease Progression | 1 |
| Geographic Atrophy | 1 |
| Macular Degeneration | 1 |
| Retinal Vein Occlusion | 1 |
| Vision Disorders | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.